Luke Pelosi
Analyst · Jefferies. Please go ahead
Okay. So on Page 11, we’ve shown the building blocks of our guide. What I’d say, that outlook is based on the environment and market conditions we see today. We’ve not factored material easing of COVID-related restrictions nor the anticipated volume increases that we expect to see with reopening activities. While we like I’m sure many of you are extremely hopeful that we can get to the other side of this pandemic as soon as possible, we’ve perceived too much uncertainty, particularly in our Canadian markets to make a call as to whether that will be three, six or nine months from now. So we’ve provided the guide and what we see today. Looking at the waterfall, we’re assuming solid waste price in the 3.5% to 4% range consistent with our past messaging. We’ve continued restrictions in many of our Canadian markets and suppressed ICI volumes across the entire platform. We’re now expecting to materially outperform this range in 2021. However, we continue to see outsized pricing opportunities within our portfolio that we intend to go after once normalicy returns. Inflationary expectations should offset some of the negative CPI adjustments we experienced in 2020 and ongoing discipline around ensuring any enterprise residential contracts are renewed at rates that meet our return thresholds should serve to support our pricing goals. On solid waste volumes, we’re seeing approximately 0.5 point to 1 point of growth. Now we know some of the expectations were higher growth numbers here, but I remind everyone of the following two points. One is we had a lower volume declines or near the much of the industry. So we’re coming off of a higher low, if you will. And two, we have a bigger proportion of our revenues coming Canada, much of which is still under some of the most restrictive lockdowns. And we think on average, maybe a quarter or two behind the U.S. in terms of reopening timelines. From a cadence perspective, we’re anticipating Q1 will be low single digits negative volume inclusive of the drag from the extra day in February, 2020, Q2 should be low to mid single digits positive on the easy comp and Q3 and Q4 flat to modestly positive. Again, should reopening activities accelerate and we see a rebound in IC&I volumes from where we are today, that would be upside for the guide. Note that in respect of commodity pricing, as we continue to move more and more of our contracts to a fixed processing charge model, we’re seeing less variability in our results from movements in commodity. The guide assumes 2021 plays out the pricing we saw at the end of 2020, which equates to approximately $9 million or $10 million of incremental revenue that flows through at a high incremental margin. On liquid and infrastructure, we’re taking a more tempered view in terms of when volumes return, despite the significant sequential increases we’ve seen in the recovery of these segments, the tough comp over Q1 2020, and the concentration of revenue in some of the harder hit regions of the Northeast and in Canada and the lag in when customers capital spending programs gear back up, all leaves us to think 2021 in more conservative growth terms. We’ve shown the two segments together, but when you unpack it, we’re thinking of liquid in the mid single digits and infrastructure basically flat. On the M&A roll forward, this reflects the approximately $900 million we previously communicated plus the late December M&A, reduced slightly in response to revise views on seasonality and the current winter situation in the South and then grossed up to the 1.34 FX rate to be presented on a constant currency basis with 2020. We’re providing our guidance, assuming a 1.27 FX rate. So that last stepping stone on the page is to bring the Canadian equivalent of our roughly $2.4 billion denominated revenue down from the average 2020 exchange rate at 1.34 to 1.27. That 4% for FX equates to about $170 million and is roughly split $50 million related to the roll over M&A and a $120 million on the base business. For every point move of the FX revenue changes by approximately $24 million and we’ll provide details of impact from FX as we report during the year. So that’s the revenue bridge. Remodeling considerations, remember we still have relative seasonality in our business, largely driven by our more Northern geographies. The cadence of the annual revenue is expected to be approximately 22% to 23% in Q1, 24% to 25% in Q2, 26% to 27% in Q3 and the balance in Q4. In terms of the M&A roll over; we expect $250 million to $260 million in Q1, $270 million-ish in Q2, approximately $280 million in Q3 and the balance in Q4. If you look at Page 12, we have shown what that revenue translates to in terms of adjusted EBITDA, free cash flow and leverage. Remember, none of this guidance includes any incremental M&A or refinancing activities. For adjusted EBITDA, we forecast to be able to drive an incremental 90 basis points of margin expansion, and we’re expecting that expansion pretty consistently across each of the segments. When you think about the EBIDTA walk, using the middle of our guidance range after adjusting for the 1.27 FX, we’re expecting about $240 million incremental EBITDA from acquisition roll over. Recall, that the majority of the roll over M&A is a blended 28% margin. So we're expecting the 2020 M&A to be slightly decretive to the solid waste margin and slightly accretive to the overall margin. The EBITDA impact of the $120 million of FX on the base business is a headwind above $37 million. Additionally, we have approximately $15 million of incremental public company and risk costs on a year-over-year basis. The balance of just under $100 million is organic growth. At the margin line when you think about the 90 or so basis points of expansion, M&A adds just under 30 basis points and commodity prices add another 10 basis points. The $15 million of incremental public and risk costs are negative 30 basis points, and the FX is negative 10 basis points. So all four of those items are basically a wash, and what you're left with is all the expansion coming organically from the same levers that we've been pulling and expected to continue to pull as we go forward. From that adjusted EBITDA, we're guiding towards an adjusted free cash flow number of $465 million to $495 million based on expected net capital expenditures around $510 million, cash taxes of $10 million, a modest improvement in working capital offset by repayment of care's deferred dollars and some incremental M&A related investment. ARO spend of about $60 million and cash interest of $300 million, which again is before considering the impact of any refinancing activity. So if you're thinking about an adjusted free cash flow walk again, using the midpoint of the guidance, take the $360 million from 2020, add the 21 incremental EBITDA, add just over $15 million for changes in working cap, then deduct $100 million for incremental CapEx, $34 million for the swing from CARES deferrals, $5 million for incremental cash interest and about $40 million for incremental ARO and cash taxes. And at the bottom of the page, if you run the math between where we went to 2020, what the model shows for 2021, you'll see the business will be elaborate down to the mid-force.